Abstract
No public abstract is available from the verified source records.
Alireza Ghoreifi, Yair Lotan
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
openalex
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Clinical characteristics and oncological outcomes of upper tract urothelial carcinoma in patients with personal or family history of lynch-syndrome-associated cancers
2026
Pembrolizumab in microsatellite instability high or mismatch repair deficient cancers: updated analysis from the phase II KEYNOTE-158 study
10.1016/j.annonc.2022.05.519 · 2022
Nivolumab and ipilimumab in advanced mismatch repair-deficient/microsatellite instability-high noncolorectal cancers: a nonrandomized clinical trial
10.1001/jamaoncol.2025.4721 · 2026
Upper tract urothelial carcinoma in the lynch syndrome tumour spectrum: a comprehensive overview from the European Association of Urology—Young Academic Urologists and the Global Society of Rare Genitourinary Tumors
10.1016/j.euo.2021.11.001 · 2022
Diagnosis and management of non-metastatic upper tract urothelial carcinoma: AUA/SUO guideline
10.1097/ju.0000000000003480 · 2023
Diagnosis and management of non-metastatic upper tract urothelial carcinoma: AUA/SUO guideline
10.1097/ju.0000000000003480 · doi-reference
Upper tract urothelial carcinoma in the lynch syndrome tumour spectrum: a comprehensive overview from the European Association of Urology—Young Academic Urologists and the Global Society of Rare Genitourinary Tumors
Confidence 95%
datacite
Confidence 0%
10.1016/j.euo.2021.11.001 · doi-reference
Nivolumab and ipilimumab in advanced mismatch repair-deficient/microsatellite instability-high noncolorectal cancers: a nonrandomized clinical trial
10.1001/jamaoncol.2025.4721 · doi-reference
Pembrolizumab in microsatellite instability high or mismatch repair deficient cancers: updated analysis from the phase II KEYNOTE-158 study
10.1016/j.annonc.2022.05.519 · doi-reference